Joan Stern, President

Meduloc is a start-up medical device company with a mission to improve outcomes and reduce complications for patients being surgically treated for fractures of the hand, foot, forearm, lower leg, and collarbone. Solutions in use today each have clinically recognized issues driving surgeons to look for a simpler, more elegant and less invasive solution.  Meduloc is design stable with our platform of Nitinol based intramedullary implants, has gained validation through proof-of-concept cadaveric labs with key opinion leader surgeons, has secured multiple patents in and outside the US, and has held a pre-submission meeting with the FDA to ensure a well-defined path to clearance based on confirmed predicates and required testing. We are currently raising a Seed round to fund the work to achieve FDA 510(k) clearance and initial market launch.